Paper of the Week 24th May 2019: What to start, what to stop, and who should do it?

2019-05-24T17:12:23+00:00

Full Reference: Gazzard G et al (2019) Lancet 2019; 393: 1505–16 Published Online March 9, 2019 http://dx.doi.org/10.1016/S0140-6736(18)32213-X This weeks blog is brought to you by: Professor Sir Muir Gray, Founding Director. WEB LINK TO PAPER Key text from the paper chosen by 3VH Background; Primary open angle glaucoma and ocular hypertension are habitually treated with eye drops that lower intraocular pressure. Selective laser trabeculoplasty is a safe alternative but is rarely used as first-line treatment. We compared the two [treatments]…. Interpretation Selective trabeculoplasty should be offered as a first-line treatment for open angle glaucoma and ocular hypertension, supporting a change in clinical practice. Discussion Use of selective laser trabeculoplasty as the first-line treatment resulted in a significant reduction [...]